Abstract 4141630: Development of a Model for MEPPC Using hiPSC-HPCs and Bioprinted Purkinje Networks

Introduction: Multifocal Ectopic Purkinje-related Premature Contractions (MEPPCs) is marked by early and frequent spontaneous membrane depolarization of the His-Purkinje cells (HPCs), which can trigger life-threatening arrhythmias and sudden death. It has been postulated that MEPPC-associated variants in SCN5A result in increased sodium influx leading to early depolarization and triggered arrhythmias. Hypothesis: Our central hypothesis is that MEPPC is caused by a gain-of-function in I NAV that leads to spontaneous HPC automaticity and triggered arrhythmogenesis originating from the CCS, which propagates into the surrounding myocardial tissue. Aims: The goals of this study are to develop a rigorous method to generate HPCs from human induced pluripotent stem cells (hiPSCs) and characterize he hiPSC-HPCs using IHC, qPCR and electrophysiology. A second objective of this study is to develop a method to bioengineer 3D Purkinje networks using state-of-the-art advances in laser based bioprinting. Methods: To generate hiPSC-HPCs, 90% of confluent hiPSCs were transitioned to GSK-3 inhibitor CHIR99021 followed by Wnt inhibitor IWP2 to generate cardiac progenitor cells. Subsequently, hiPSCs were exposed to sodium nitroprusside on day 5, which led to spontaneous beating after 10 days, followed by a change in cell morphology, transitioning to large and cylindrical cells indicative of HPCs. To generate 3D Purkinje networks, we used a commercial laser based bioprinter, the Lumen X. We optimized our bioink formulation and selected 90% PEGDA as our base polymer, supplemented with 10% GELMA. Results: Robust expression of both CNTN2, an HPC-specific marker, and HCN4, unique to cardiac nodal and conduction cells, was observed by IHC ( Fig. 1A ). We successfully bioprinted Purkinje networks ( Fig. 1B ) and cell viability was confirmed using a live/dead assay. Phenotype of hiPSC-HPCs within the bioprinted Purkinje networks was confirmed using CNTN2 staining ( Fig. 1C ), a marker specific for Purkinje cells. Conclusion: Our results demonstrate our ability to successfully reprogram hiPSCs to form HPCs and our ability to utilize these cells to bioprint human 3D Purkinje networks.

Authors

Institutions

Publication Details

Journal
Circulation
Published
2024-11-12
DOI
https://doi.org/10.1161/circ.150.suppl_1.4141630
Primary Topic
3D Printing in Biomedical Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract 4141630: Development of a Model for MEPPC Using hiPSC-HPCs and Bioprinted Purkinje Networks

Andrew Paul Landstrom, Pengfei Ji, Ravi K. Birla, Bo Sun et al.
Circulation
3D Printing in Biomedical Research
article

Abstract 4141630: Development of a Model for MEPPC Using hiPSC-HPCs and Bioprinted Purkinje Networks

Andrew Paul Landstrom, Pengfei Ji, Ravi K. Birla, Bo Sun, Jeffrey S. Heinle, Gabrielle Monaco
article en

Abstract

Introduction: Multifocal Ectopic Purkinje-related Premature Contractions (MEPPCs) is marked by early and frequent spontaneous membrane depolarization of the His-Purkinje cells (HPCs), which can trigger life-threatening arrhythmias and sudden death. It has been postulated that MEPPC-associated variants in SCN5A result in increased sodium influx leading to early depolarization and triggered arrhythmias. Hypothesis: Our central hypothesis is that MEPPC is caused by a gain-of-function in I NAV that leads to spontaneous HPC automaticity and triggered arrhythmogenesis originating from the CCS, which propagates into the surrounding myocardial tissue. Aims: The goals of this study are to develop a rigorous method to generate HPCs from human induced pluripotent stem cells (hiPSCs) and characterize he hiPSC-HPCs using IHC, qPCR and electrophysiology. A second objective of this study is to develop a method to bioengineer 3D Purkinje networks using state-of-the-art advances in laser based bioprinting. Methods: To generate hiPSC-HPCs, 90% of confluent hiPSCs were transitioned to GSK-3 inhibitor CHIR99021 followed by Wnt inhibitor IWP2 to generate cardiac progenitor cells. Subsequently, hiPSCs were exposed to sodium nitroprusside on day 5, which led to spontaneous beating after 10 days, followed by a change in cell morphology, transitioning to large and cylindrical cells indicative of HPCs. To generate 3D Purkinje networks, we used a commercial laser based bioprinter, the Lumen X. We optimized our bioink formulation and selected 90% PEGDA as our base polymer, supplemented with 10% GELMA. Results: Robust expression of both CNTN2, an HPC-specific marker, and HCN4, unique to cardiac nodal and conduction cells, was observed by IHC ( Fig. 1A ). We successfully bioprinted Purkinje networks ( Fig. 1B ) and cell viability was confirmed using a live/dead assay. Phenotype of hiPSC-HPCs within the bioprinted Purkinje networks was confirmed using CNTN2 staining ( Fig. 1C ), a marker specific for Purkinje cells. Conclusion: Our results demonstrate our ability to successfully reprogram hiPSCs to form HPCs and our ability to utilize these cells to bioprint human 3D Purkinje networks.

CirculationVol. 150(Suppl_1)
Duke University (US), Baylor College of Medicine (US), Texas Children's Hospital (US)
Openalex Percentile: Top 81%
3D Printing in Biomedical Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.